Globus Medical GMED Change in fair value of contingent consideration
Change in fair value of contingent consideration at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's change in fair value of contingent consideration.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Globus Medical's change in fair value of contingent consideration?
- Globus Medical (GMED) reported change in fair value of contingent consideration of $6.35M in Q1 2026.
- How has Globus Medical's change in fair value of contingent consideration changed year-over-year?
- Globus Medical's change in fair value of contingent consideration increased by 3703.6% year-over-year, from $167K to $6.35M.
- What is the long-term trend for Globus Medical's change in fair value of contingent consideration?
- Over 2 years (2021 to 2023), Globus Medical's change in fair value of contingent consideration has grown at a 1.8% compound annual growth rate (CAGR), from $16.81M to $17.43M.
- What does change in fair value of contingent consideration mean?
- The change in the estimated value of future payouts owed to sellers of acquired companies.
- How do you interpret change in fair value of contingent consideration?
- Changes reflect updated expectations regarding the performance of acquired businesses relative to initial projections.
- How does change in fair value of contingent consideration compare across companies?
- Common in companies that use earn-out structures in their M&A strategy.